<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18170" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>BAX Gene</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Carpenter</surname>
            <given-names>Randy</given-names>
          </name>
          <aff>University of Tennessee Health Science Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Brady</surname>
            <given-names>Mark F.</given-names>
          </name>
          <aff>Alpert Medical School of Brown University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Randy Carpenter declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mark Brady declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18170.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The mechanisms of apoptosis may help elucidate the pathologies of uncontrolled cell growth or death. Apoptosis is under the mediation of&#x000a0;2 major pathways: the extrinsic or death receptor pathway and the intrinsic or mitochondrial pathway.<xref ref-type="bibr" rid="article-18170.r1">[1]</xref><xref ref-type="bibr" rid="article-18170.r2">[2]</xref>&#x000a0;The intrinsic&#x000a0;pathway is controlled and regulated by the Bcl-2 (B-cell lymphoma 2) family of proteins. The proteins in this family can be classified by their anti-apoptotic (Bcl-2, Bcl-x, Bcl-w, Mcl-1, and A1/Bfl-1) or pro-apoptotic (Bax, Bak, and Bok/Mtd) actions.<xref ref-type="bibr" rid="article-18170.r3">[3]</xref>&#x000a0;Both pathways result in caspase activation, leading to the termination of cell life.<xref ref-type="bibr" rid="article-18170.r4">[4]</xref>&#x000a0;The BAX&#x000a0;gene (Bcl-2 Associated X-protein) is a pro-apoptotic&#x000a0;member of the Bcl-2 gene family; it encodes a 21-kDa protein named BAX-alpha, whose association with Bcl-2 researchers believe plays a critical role in regulating intrinsic apoptosis.<xref ref-type="bibr" rid="article-18170.r4">[4]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-18170.s2" sec-type="Development">
        <title>Development</title>
        <p>Research has&#x000a0;shown&#x000a0;that the Bax gene is located on chromosome 19 by utilizing fluorescent in-situ hybridization and human-hamster somatic cell hybrid DNA.<xref ref-type="bibr" rid="article-18170.r4">[4]</xref>&#x000a0;Using isolated mitochondria treated to block permeability transition (PT) mitochondrial pore opening, scientists determined that Bax protein allows membrane depolarization and release of mitochondrial contents, including cytochrome c, via a Ca+-dependent opening of&#x000a0;permeability transition pores.<xref ref-type="bibr" rid="article-18170.r5">[5]</xref>&#x000a0;However, PTP-/- knockout mice still exhibit Bax-dependent cell death; therefore, the suggestion has been that Bax is capable of forming pores in the mitochondrial outer membrane (MOM) on its own by inserting its amphipathic alpha-helical structure directly into the MOM.<xref ref-type="bibr" rid="article-18170.r6">[6]</xref></p>
      </sec>
      <sec id="article-18170.s3" sec-type="Cellular">
        <title>Cellular</title>
        <p>The intrinsic pathway of apoptosis becomes activated via decreased survival signals. The Bax gene encodes BCL2L4 protein that, upon activation, heterodimerizes with Bcl2 family proteins and alters cellular mitochondria to induce cell death.<xref ref-type="bibr" rid="article-18170.r7">[7]</xref>&#x000a0; Bax protein is cytosolic in healthy cells with minimal binding and insertion into the outer mitochondrial membrane. Pro-survival signals, such as Bcl-xl and Bcl-2,&#x000a0;ensure Bax does not accumulate on the outer mitochondrial membrane of healthy cells.<xref ref-type="bibr" rid="article-18170.r8">[8]</xref> Although the complete mechanism by which Bax permeabilizes the&#x000a0;MOM is unclear, it is known that Bax, upon activation, causes membrane depolarization and mitochondrial leaking of contents such as cytochrome c.<xref ref-type="bibr" rid="article-18170.r3">[3]</xref>&#x000a0;Morphological changes in the apoptotic cell include pyknosis (nuclear condensation and shrinkage), cell shrinkage, and membrane blebbing, leading to the release of vesicles containing cellular contents phagocytosed by surviving cells.<xref ref-type="bibr" rid="article-18170.r9">[9]</xref></p>
      </sec>
      <sec id="article-18170.s4" sec-type="Biochemical">
        <title>Biochemical</title>
        <p>Due to alternative splicing, the Bax gene produces multiple isoforms, with Bax-alpha being the most predominant.<xref ref-type="bibr" rid="article-18170.r4">[4]</xref>&#x000a0;The hydrophobic pocket of the BH3 domain is the active binding site for regulators such as BH3 and Bcl-xl pro- and anti-apoptotic members of the Bcl-2 family.<xref ref-type="bibr" rid="article-18170.r3">[3]</xref>&#x000a0;Transcriptional regulation of the Bax gene largely occurs by tumor suppressor P53.<xref ref-type="bibr" rid="article-18170.r1">[1]</xref>&#x000a0; Although the conformational changes that occur upon activation are not entirely understood, it is known that the carboxy-terminal end of the protein is responsible for mitochondrial membrane location and binding.<xref ref-type="bibr" rid="article-18170.r6">[6]</xref> Once bound, the BH1 and BH2 domains are suspected to be pore-forming, resulting in increased membrane permeability and leakage of interspace proteins, which induce downstream cellular effects that result in cell death.<xref ref-type="bibr" rid="article-18170.r6">[6]</xref><xref ref-type="bibr" rid="article-18170.r3">[3]</xref></p>
      </sec>
      <sec id="article-18170.s5" sec-type="Molecular Level&#x0000d;&#x0000a;">
        <title>Molecular Level
</title>
        <p>Bax and other pro-apoptotic members of the Bcl-2 family contain 4 Bcl-2 homologous (BH) domains. The BH3 domain contains the active binding site, which consists of alpha-helices embedded within a hydrophobic groove.<xref ref-type="bibr" rid="article-18170.r3">[3]</xref>&#x000a0;The BH3 domain allows for heterodimerization with Bcl-2 and Bcl-xl, while its hydrophobic c-terminal allows for outer mitochondrial membrane binding. BH1 and BH2 domains are suspected to be the pore-forming domains of the protein.<xref ref-type="bibr" rid="article-18170.r6">[6]</xref>&#x000a0;The full extent of the conformational changes that occur during protein binding to both regulators and the MOM has yet to be seen. Still, it is an area of research that may elucidate possible pharmacological interventions in pathological processes that involve apoptotic dysregulation.&#x000a0;</p>
      </sec>
      <sec id="article-18170.s6" sec-type="Function">
        <title>Function</title>
        <p>The Bax gene encodes BCL2L4 protein that, upon activation, heterodimerizes with Bcl2 family proteins and alters cellular mitochondria to induce cell death.<xref ref-type="bibr" rid="article-18170.r7">[7]</xref>&#x000a0;When Bax protein is activated, it binds and induces MOM permeabilization.&#x000a0;Such permeabilization results in mitochondrial swelling and rupture with subsequent leakage of intermembrane space proteins, specifically cytochrome c and endonuclease G.<xref ref-type="bibr" rid="article-18170.r10">[10]</xref>&#x000a0; Every mechanism in which&#x000a0;Bax increases mitochondrial membrane permeability is poorly understood, but scientists know that binding to permeability transition pore (PTP)&#x000a0;causes conformational changes that increase permeability.<xref ref-type="bibr" rid="article-18170.r11">[11]</xref> However, PTP-knockout mice still exhibit Bax-dependent cell death; therefore, there have been suggestions that Bax can form pores in the MOM by inserting its amphipathic alpha-helical structure directly into the MOM.<xref ref-type="bibr" rid="article-18170.r6">[6]</xref></p>
      </sec>
      <sec id="article-18170.s7" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>Bax protein exists constitutively in the cytoplasm until activated. It binds to multiple anti-apoptotic proteins, such as Bcl-xl, that inhibit Bax translocation to the MOM; therefore, Bax-mediated apoptosis depends on the concentration of both pro- and anti-apoptotic proteins.<xref ref-type="bibr" rid="article-18170.r6">[6]</xref>&#x000a0;Bax becomes activated by binding upregulated death signals such as BH3-only proteins or t-Bid at its BH3 hydrophobic pocket domain. Activation causes conformational changes that lead to translocation to the MOM, where Bax induces mitochondrial outer membrane permeabilization (MOMP) by&#x000a0;2 possible mechanisms described above.<xref ref-type="bibr" rid="article-18170.r6">[6]</xref><xref ref-type="bibr" rid="article-18170.r2">[2]</xref>&#x000a0;MOMP leads to mitochondrial swelling and rupture, causing the release of periplasmic proteins such as cytochrome C.<xref ref-type="bibr" rid="article-18170.r2">[2]</xref>&#x000a0;Cytochrome C binds and activates cytosolic caspases, which are known to be the effector proteases of cell death.<xref ref-type="bibr" rid="article-18170.r2">[2]</xref><xref ref-type="bibr" rid="article-18170.r10">[10]</xref></p>
      </sec>
      <sec id="article-18170.s8" sec-type="Testing">
        <title>Testing</title>
        <p>Researchers originally discovered Bax using immunoprecipitation studies with Bcl-2.<xref ref-type="bibr" rid="article-18170.r6">[6]</xref>&#x000a0;They discovered its genetic location using FISH and parsed out its function using various methods.<xref ref-type="bibr" rid="article-18170.r5">[5]</xref>&#x000a0;Most recent studies aim to identify Bax's role in pathological diseases using genetic knockout models or virally infected over-expression of Bax.<xref ref-type="bibr" rid="article-18170.r2">[2]</xref><xref ref-type="bibr" rid="article-18170.r12">[12]</xref></p>
      </sec>
      <sec id="article-18170.s9" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Because of the Bax gene's role in cell apoptosis, dysfunction carries links to various pathologies related to cell accumulation (i.e., cancer) or cell loss (ie, heart failure, Alzheimer&#x000a0;disease).<xref ref-type="bibr" rid="article-18170.r2">[2]</xref>&#x000a0;Tumorigenesis largely depends on the cell's ability to overcome cell cycle regulators and apoptosis. Research has shown that both&#x000a0;loss of function and gain of function mutations in Bcl-2 family proteins, including Bax, increase the likelihood of human tumorigenesis.<xref ref-type="bibr" rid="article-18170.r13">[13]</xref>&#x000a0;Research demonstrates that Bax deletion increases the oncogenic gene activation and the progression of certain cancers, such as Philadelphia-positive leukemia.<xref ref-type="bibr" rid="article-18170.r12">[12]</xref></p>
      </sec>
      <sec id="article-18170.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Bax dysregulation can lead to apoptotic dysfunction, increasing the likelihood of multiple pathologies. As a tumor suppressor gene, Bax has a critical role in preventing tumorigenesis, and loss of function often occurs in human tumors. Loss of function mutations can also lead to incomplete negative selection and peripheral tolerance dysfunction, thus causing autoimmune complications. Chronic neurodegenerative conditions, such as&#x000a0;Huntington disease, Parkinson disease, or Alzheimer disease,&#x000a0;often depend on&#x000a0;aberrant&#x000a0;apoptotic cell death.&#x000a0;Lastly, although necrosis is the primary mechanism of injury during myocardial infarction, it has been seen that reperfusion injury is an apoptosis-driven event.<xref ref-type="bibr" rid="article-18170.r13">[13]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-18170.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18170&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18170">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18170/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18170">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-18170.s12">
        <title>References</title>
        <ref id="article-18170.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chipuk</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kuwana</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bouchier-Hayes</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Droin</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Newmeyer</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Schuler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.</article-title>
            <source>Science</source>
            <year>2004</year>
            <month>Feb</month>
            <day>13</day>
            <volume>303</volume>
            <issue>5660</issue>
            <fpage>1010</fpage>
            <page-range>1010-4</page-range>
            <pub-id pub-id-type="pmid">14963330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18170.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reed</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of apoptosis.</article-title>
            <source>Am J Pathol</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>157</volume>
            <issue>5</issue>
            <fpage>1415</fpage>
            <page-range>1415-30</page-range>
            <pub-id pub-id-type="pmid">11073801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18170.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martinou</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Youle</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics.</article-title>
            <source>Dev Cell</source>
            <year>2011</year>
            <month>Jul</month>
            <day>19</day>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>92</fpage>
            <page-range>92-101</page-range>
            <pub-id pub-id-type="pmid">21763611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18170.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Apte</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Mattei</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>BR</given-names>
              </name>
            </person-group>
            <article-title>Mapping of the human BAX gene to chromosome 19q13.3-q13.4 and isolation of a novel alternatively spliced transcript, BAX delta.</article-title>
            <source>Genomics</source>
            <year>1995</year>
            <month>Apr</month>
            <day>10</day>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>592</fpage>
            <page-range>592-4</page-range>
            <pub-id pub-id-type="pmid">7607685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18170.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Narita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chittenden</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lutz</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Matsuda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tsujimoto</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1998</year>
            <month>Dec</month>
            <day>08</day>
            <volume>95</volume>
            <issue>25</issue>
            <fpage>14681</fpage>
            <page-range>14681-6</page-range>
            <pub-id pub-id-type="pmid">9843949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18170.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shamas-Din</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kale</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Leber</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of action of Bcl-2 family proteins.</article-title>
            <source>Cold Spring Harb Perspect Biol</source>
            <year>2013</year>
            <month>Apr</month>
            <day>01</day>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>a008714</fpage>
            <pub-id pub-id-type="pmid">23545417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18170.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oltvai</surname>
                <given-names>ZN</given-names>
              </name>
              <name>
                <surname>Milliman</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Korsmeyer</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.</article-title>
            <source>Cell</source>
            <year>1993</year>
            <month>Aug</month>
            <day>27</day>
            <volume>74</volume>
            <issue>4</issue>
            <fpage>609</fpage>
            <page-range>609-19</page-range>
            <pub-id pub-id-type="pmid">8358790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18170.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edlich</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cleland</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Arnoult</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Neutzner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tjandra</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Youle</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Bcl-x(L) retrotranslocates Bax from the mitochondria into the cytosol.</article-title>
            <source>Cell</source>
            <year>2011</year>
            <month>Apr</month>
            <day>01</day>
            <volume>145</volume>
            <issue>1</issue>
            <fpage>104</fpage>
            <page-range>104-16</page-range>
            <pub-id pub-id-type="pmid">21458670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18170.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Gueydan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Plasma membrane changes during programmed cell deaths.</article-title>
            <source>Cell Res</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-21</page-range>
            <pub-id pub-id-type="pmid">29076500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18170.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuwana</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Newmeyer</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <article-title>Bcl-2-family proteins and the role of mitochondria in apoptosis.</article-title>
            <source>Curr Opin Cell Biol</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>691</fpage>
            <page-range>691-9</page-range>
            <pub-id pub-id-type="pmid">14644193</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18170.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwarz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Andrade-Navarro</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Mitochondrial carriers and pores: key regulators of the mitochondrial apoptotic program?</article-title>
            <source>Apoptosis</source>
            <year>2007</year>
            <month>May</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>869</fpage>
            <page-range>869-76</page-range>
            <pub-id pub-id-type="pmid">17453157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18170.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Sha</surname>
                <given-names>MQ</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>[BAX Deletion Accelerates Progression of BCR-ABL-Induced B-ALL in Mice].</article-title>
            <source>Zhongguo Shi Yan Xue Ye Xue Za Zhi</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-33</page-range>
            <pub-id pub-id-type="pmid">32027249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18170.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kelly</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Strasser</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy.</article-title>
            <source>Cell Death Differ</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>9</issue>
            <fpage>1414</fpage>
            <page-range>1414-24</page-range>
            <pub-id pub-id-type="pmid">21415859</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
